Sellas Life Sciences SLS
$13.66 −$1.20 (-8.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.21 +4.03%
Open$14.98
Prev close$14.86
Day range$13.39 – $15.19
Volume15.48M
Market cap$2.78B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$11.31M-59.7% YoY
Net profit-$10.09M-48.6% YoY
Diluted EPS-$0.05+16.7% YoY
Free cash flow-$5.94M+16.0% YoY
Operating cash flow-$5.94M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-40.3%
Return on assets-37.1%
Return on invested capital-44.2%
Current ratio14.92
Liabilities / assets6.6%
Cash & investments$134.71M
Total debt$0.00
Net cash (debt)$134.71M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $11.31M | $10.63M | $9.25M | $28.27M | $8.26M |
| Selling and Admin Expenses | $4.28M | $4.36M | $4.12M | $12.25M | $3.53M |
| -General & Admin Expense | $4.28M | $4.36M | $4.12M | $12.25M | $3.53M |
| Research & Development | $7.03M | $6.27M | $5.13M | $16.02M | $4.73M |
| Operating Profit | -$11.31M | -$10.63M | -$9.25M | -$28.27M | -$8.26M |
| Net Non-Operating Interest Income (Expense) | $1.22M | $1.02M | $845,000.00 | $1.41M | $597,000.00 |
| Non-Operating Interest Income | $1.22M | $1.02M | $845,000.00 | $1.41M | $597,000.00 |
| Pretax Profit | -$10.09M | -$9.61M | -$8.41M | -$26.86M | -$7.66M |
| Net Profit | -$10.09M | -$9.61M | -$8.41M | -$26.86M | -$7.66M |
| Profit from Continuing Operations | -$10.09M | -$9.61M | -$8.41M | -$26.86M | -$7.66M |
| Net Income to Parent Company | -$10.09M | -$9.61M | -$8.41M | -$26.86M | -$7.66M |
| Net Income to Common Stockholders | -$10.09M | -$9.61M | -$8.41M | -$26.86M | -$7.66M |
| Basic EPS | -$0.05 | -$0.05 | -$0.05 | -$0.25 | -$0.05 |
| Diluted EPS | -$0.05 | -$0.05 | -$0.05 | -$0.25 | -$0.05 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $141.09M | $145.38M | $114.18M | $78.35M | $78.35M |
| Total Current Assets | $138.57M | $142.51M | $111.17M | $75.21M | $75.21M |
| Cash and Cash Equivalents & Short-Term Investments | $134.71M | $138.34M | $107.10M | $71.79M | $71.79M |
| -Cash and Cash Equivalents | $134.71M | $138.34M | $107.10M | $71.79M | $71.79M |
| Prepaid Assets | $3.46M | $4.06M | $3.97M | $3.10M | $3.10M |
| Restricted Cash | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| Other Current Assets | $303,000.00 | – | – | $223,000.00 | $223,000.00 |
| Total Non-Current Assets | $2.52M | $2.88M | $3.01M | $3.13M | $3.13M |
| Net PPE | $578,000.00 | $710,000.00 | $839,000.00 | $963,000.00 | $963,000.00 |
| -Gross PPE | $578,000.00 | $710,000.00 | $839,000.00 | $963,000.00 | $963,000.00 |
| Goodwill and Other Intangible Assets | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M |
| -Goodwill | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M |
| Other Non-Current Assets | $25,000.00 | $253,000.00 | $255,000.00 | $257,000.00 | $257,000.00 |
| Total Liabilities | $9.29M | $7.73M | $6.77M | $7.47M | $7.47M |
| Total Current Liabilities | $9.29M | $7.57M | $6.46M | $7.02M | $7.02M |
| Payables | $2.09M | $3.09M | $3.63M | $2.95M | $2.95M |
| -Accounts Payable | $2.09M | $3.09M | $3.63M | $2.95M | $2.95M |
| Current Accrued Expenses | $4.94M | $2.69M | $1.61M | $1.73M | $1.73M |
| Short-Term Debt and Capital Lease Obligation | $599,000.00 | $580,000.00 | $562,000.00 | $544,000.00 | $544,000.00 |
| -Current Capital Lease Obligation | $599,000.00 | $580,000.00 | $562,000.00 | $544,000.00 | $544,000.00 |
| Other Current Liabilities | $87,000.00 | $58,000.00 | $24,000.00 | $42,000.00 | $42,000.00 |
| Total Non-Current Liabilities | $0.00 | $157,000.00 | $309,000.00 | $457,000.00 | $457,000.00 |
| Long Term Debt and Capital Lease Obligation | $0.00 | $157,000.00 | $309,000.00 | $457,000.00 | $457,000.00 |
| -Long Term Capital Lease Obligation | $0.00 | $157,000.00 | $309,000.00 | $457,000.00 | $457,000.00 |
| Total Equity | $131.81M | $137.66M | $107.41M | $70.87M | $70.87M |
| Stockholders' Equity | $131.81M | $137.66M | $107.41M | $70.87M | $70.87M |
| Capital Stock | $20,000.00 | $20,000.00 | $18,000.00 | $15,000.00 | $15,000.00 |
| -Common Stock | $20,000.00 | $20,000.00 | $18,000.00 | $15,000.00 | $15,000.00 |
| Additional Paid-In Capital | $434.88M | $430.64M | $390.79M | $345.84M | $345.84M |
| Retained Earnings | -$303.09M | -$293.00M | -$283.40M | -$274.99M | -$274.99M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$5.94M | -$7.59M | -$8.85M | -$28.39M | -$4.92M |
| Net cash flow from continuing operations | -$5.94M | -$7.59M | -$8.85M | -$28.39M | -$4.92M |
| Net Income from Continuing Operations | -$10.09M | -$9.61M | -$8.41M | -$26.86M | -$7.66M |
| Other Non-Cash Items | $152,000.00 | $154,000.00 | $153,000.00 | $597,000.00 | $154,000.00 |
| Change in Working Capital | $2.07M | $848,000.00 | -$1.39M | -$4.08M | $2.14M |
| -Change in Prepaid Assets | $527,000.00 | -$88,000.00 | -$652,000.00 | -$968,000.00 | $1.09M |
| -Change in Payables and Accrued Expense | $1.70M | $1.10M | -$579,000.00 | -$2.48M | $1.21M |
| -Change in Other Current Liabilities | -$158,000.00 | -$159,000.00 | -$159,000.00 | -$635,000.00 | -$159,000.00 |
| Financing Cash Flow | $2.31M | $38.83M | $44.15M | $86.30M | $32.39M |
| Net Cash Flow from Continuing Financing Activities | $2.31M | $38.83M | $44.15M | $86.30M | $32.39M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | $23.05M | $0.00 |
| Proceeds from Stock Option Exercised | $2.31M | $38.83M | $44.15M | $63.77M | $32.92M |
| Ending Cash Balance | $134.81M | $138.44M | $107.20M | $71.89M | $71.89M |
| Net Change in Cash | -$3.63M | $31.25M | $35.30M | $57.91M | $27.47M |
| Beginning Cash Balance | $138.44M | $107.20M | $71.89M | $13.99M | $44.42M |
| Free Cash Flow | -$5.94M | -$7.59M | -$8.85M | -$28.39M | -$4.92M |
| Net Other Financing Charges | – | – | – | -$527,000.00 | – |
No comments yet — be the first to weigh in on SLS.
Sign in to join the discussion.